NASDAQ:BCRX

Biocryst Pharmaceuticals Stock News

etoro logo Buy BCRX
*Your capital is at risk
$9.31
+0.170 (+1.86%)
At Close: Jun 23, 2026
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) saw some unusual options trading activity on Monday. Traders purchased 7,705 call options on the company. This represents an increase of 170% compared to t
BioCryst (BCRX) starts recruitment for a clinical study on its pipeline candidate galidesivir to treat patients with the deadly coronavirus disease.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE